CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has announced that CHL Group, associated with a key shareholder and director, has purchased equity in NCP, now making NCP a connected entity. This acquisition affects the continuing operations under their existing Consolidated Services Agreement, which includes leasing and energy supply for CSPC NZP’s manufacturing. The company will adhere to the Listing Rules by conducting annual reviews, disclosures, and obtaining shareholder approval for any changes to this agreement.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
